↑ Rising
Business
Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers
6sources
6articles
4velocity
+31%since first seen
2h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (6)
- Sangamo Therapeutics files for bankruptcy as Lilly and Astellas split assets The Business Journals · 8h ago
- Sangamo Therapeutics Files for Chapter 11 Bankruptcy Protection citybiz · 8h ago
- Gene Therapy Developer Sangamo Hits Ch. 11 With Sale Plans Law360 · 8h ago
- Sangamo Therapeutics Sets Stalking Horse Sales: $50M to Eli Lilly, Up to $50M to Astellas TradingView · 8h ago
- UPDATE: Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy BioSpace · 8h ago
- Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers Fierce Biotech · 8h ago
Related trends
▲ Peaking
Business
Cerebras Stock Sinks After First Earnings Report. AI Demand Is Forcing Tough Choices.
▲ Peaking
Business
Dow Jones Adds 5th Magnificent Seven Stock
▲ Peaking
Business
Micron’s Red-Hot Run Hits a Wall as Stock Suffers Worst Drop in More Than a Year
▲ Peaking
Business
Computer wars heat up as Chinese supercomputer tops all US machines in speed for first time since 2017
▲ Peaking
Business
N.S.A. Lost Access to Powerful A.I. Model Amid Anthropic Dispute
▲ Peaking
Business